1-3 of 3
Gary Ulaner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

Eli L. Diamond, Benjamin Durham, Ahmet Dogan, Mariko Yabe, Kseniya Petrova-Drus, Raajit K. Rampal, Raajit K. Rampal, Gary Ulaner, Mario Lacouture, Veronica Rotemberg, Anne Covey, Lynn Brody, Omar Abdel-Wahab
Journal: Blood
Blood (2023) 142 (Supplement 1): 1812.
https://doi.org/10.1182/blood-2023-187508
Published: 2023
Journal Articles

Phase 2 Trial of Single-Agent Cobimetinib for Adults with BRAF V600-Mutant and Wild-Type Histiocytic Disorders

Eli L Diamond, MD, Benjamin H Durham, MD BS, Ahmet Dogan, MD PhD, David M. Hyman, MD, Raajit K. Rampal, MD PhD, Gary Ulaner, MD, Lynn Brody, MD, Omar Abdel-Wahab, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 257.
https://doi.org/10.1182/blood.V130.Suppl_1.257.257
Published: 2017
Journal Articles

Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-Basket Study

Eli L. Diamond, Vivek Subbiah, Craig Lockhart, Jean-Yves Blay, Jason E. Faris, Igor Puzanov, Ian Chau, Noopur S. Raje, Jürgen S. Wolf, Joe Erinjeri, Jean Torrisi, Gary Ulaner, Mario Lacouture, Susan Robson, Martina Makrutzki, Elena Elez, Josep Tabernero, Omar Abdel-Wahab, MD, Jose Baselga, David M. Hyman
Journal: Blood
Blood (2016) 128 (22): 480.
https://doi.org/10.1182/blood.V128.22.480.480
Published: 2016